Some studies have shown that the expression of DARS2 has a certain predictive effect on bladder cancer (BLCA) and LUAD [10–15], and has been identified as an hepatocarcinogenesis (HCC) oncogene that promotes the progression of HCC cell cycle and inhibits apoptosis of HCC cells [16]. This evidence concerns the gene DARS2 and bladder transitional cell carcinoma.